Advertisement
Legal
Subscribe to Legal

The Lead

Sandoz seeks to overturn $38M judgement

June 17, 2015 11:49 am | by The Associated Press | News | Comments

A drug manufacturer is asking the Mississippi Supreme Court to reverse a $38.2 million judgment for the state in a Medicaid drug-pricing lawsuit.

Murder charges for woman who took pills to terminate pregnancy

June 10, 2015 11:42 am | by Russ Bynum, Associated Press | News | Comments

"I have been involved in the pro-life movement for well over 20 years, and I'm not aware of a...

Prison for woman who replaced fish oil with seizure meds and stool softeners

June 5, 2015 6:45 am | by Associated Press | News | Comments

U.S. Food and Drug Administration investigators determined the bottle contained 10 fish oil...

Florida doctor accused of giving cancer patients unapproved drugs

June 5, 2015 6:35 am | by Kelli Kennedy, AP | News | Comments

Federal officials said patients were unaware that for the past six years they were receiving...

View Sample

FREE Email Newsletter

FDA panel backs female libido pill

June 5, 2015 6:01 am | by Matthew Perrone, AP | News | Comments

A decade-spanning search for a female equivalent to Viagra took a step forward, as government experts recommended approval for a pill to boost sexual desire in women. However, the endorsement came with safety reservations due to drug side effects.

Teva looks to raise stake in Mylan following takeover bid

June 3, 2015 5:21 pm | by Andy Szal, Digital Reporter | News | Comments

The ongoing spat between generic pharmaceutical rivals Teva and Mylan shows no signs of slowing down.

Halozyme enters collaboration and licensing agreement with AbbVie

June 3, 2015 11:03 am | by PR Newswire | News | Comments

Halozyme Therapeutics announced a global collaboration and license agreement with AbbVie to develop and commercialize products.

Advertisement

Teva launches Actonel generic tablets

June 1, 2015 11:11 am | by Business Wire | News | Comments

Teva was first to file, making the product eligible for 180 days of market exclusivity.

Cities sue over recreational pot taxes

May 29, 2015 11:23 am | by IVAN MORENO, Associated Press | News | Comments

Three cities are suing over the collection of taxes from recreational marijuana businesses already being taxed by the cities and the state.

Actavis confirms court ruling related to NAMENDA

May 26, 2015 11:17 am | by PRNewswire | News | Comments

"While we are disappointed by the Court's decision to uphold this ruling, we intend to continue our strong efforts to convey the significant benefits of NAMENDA XR@ to physicians, patients and caregivers," said Brent Saunders, CEO and President of Actavis.

Massachusetts Court Rules in Tainted Drug Case

May 19, 2015 10:51 am | by Philip Marcelo, Associated Press | News | Comments

Thousands of defendants convicted of drug crimes after a chemist in a state lab tampered with evidence can't be charged with more serious crimes or given harsher sentences if granted a new trial.

J&J Settles $7.8 Million Lawsuit

May 19, 2015 10:35 am | by AP | News | Comments

Three years ago a jury found that a subsidiary, Janssen Pharmaceutical, committed Medicaid fraud and violated a state law in its labeling and marketing of Risperdal. A $1.2 billion fine was initially imposed on Johnson & Johnson.

Advertisement

FTC Seeks More Info From Pfizer About Hospira Acquisition

May 15, 2015 12:04 pm | by Pfizer Inc. | News | Comments

Pfizer Inc. today announced that it has received a request for additional information from the FTC with respect to its previously announced proposed acquisition of Hospira.

Continuing Story: Judge Won't Toss Out FedEx Drug Indictment

May 15, 2015 11:47 am | by Sudhin Thanawala, Associated Press | News | Comments

U.S. District Court Judge Charles Breyer said the acts alleged by prosecutors do not fall under an exemption in federal drug law for transportation companies such as FedEx.

Governor Says Nebraska Has Ordered New Death Penalty Drugs

May 15, 2015 11:39 am | by Grant Schulte, The Associated Press | News | Comments

Steps are being taken to resume executions in a state that hasn't imposed the death penalty since 1997.

Colombian Ban on Anti-Coca Herbicide is Bittersweet

May 14, 2015 11:54 am | by Jacobo Garcia, Associated Press | News | Comments

Colombian President Santos last week decided to halt fumigation in the wake of a report by a research arm of the World Health Organization classifying (anti-coca) glyphosate as a probable carcinogen.

Personalized Medicine Gaining Traction, Facing Challenges

May 14, 2015 11:48 am | by Tufts Center for the Study of Drug Development | News | Comments

Thirteen percent of drugs marketed in the United States today post pharmacogenomic information on the label, but developers continue to encounter compliance challenges.

Advertisement

FedEx Seeks Dismissal of Federal Drug Indictment

May 14, 2015 11:41 am | by The Associated Press | News | Comments

Attorneys for FedEx are set to appear in court, as they seek to dismiss a federal indictment that accuses the company of knowingly shipping illegal prescription drugs from two online pharmacies.

Moving Up the Value Chain

May 14, 2015 11:35 am | by Lance Ellisor, VP of Product Management at Mitratech | News | Comments

How pharmaceutical legal departments can create a competitive advantage for the enterprise.

ProPharma Group Acquires PROSAR

May 14, 2015 11:21 am | by ProPharma Group | News | Comments

ProPharma Group, a  compliance services company, today announced its acquisition of PROSAR, a provider of pharmacovigilance and medical information services.

Pennsylvania Senate Passes Medical Marijuana Bill

May 13, 2015 11:36 am | by Marc Levy, Associated Press | News | Comments

State senators, for a second time, have sent legislation legalizing medical marijuana to the House of Representatives, where the GOP majority has held hearings but given no certain signs of support.

ANI Acquires Rights to Testosterone Gel 1%

May 13, 2015 11:31 am | by ANI Pharmaceuticals | News | Comments

ANI Pharmaceuticals has acquired the approved new drug application ("NDA") for a testosterone gel 1% product previously licensed to Teva Pharmaceuticals.

Obamacare Ruling Could Impact States, But Not Lawmakers

May 13, 2015 11:26 am | by Ricardo Alonso-Zaldivar, Associated Press | News | Comments

If the Supreme Court rules the way most Republicans want in the latest health overhaul case, GOP lawmakers who now have insurance coverage under President Barack Obama's law may wind up with some explaining to do.

FDA Panel Backs Vertex Combination Pill for Cystic Fibrosis

May 13, 2015 11:23 am | by Matthew Perrone, AP Health Writer | News | Comments

Federal health advisers recommended approval for an experimental combination drug to treat cystic fibrosis, despite unresolved questions about the benefit of one of the pill's two ingredients.

FDA Fast Tracks Sucampo's Cobiprostone

May 11, 2015 10:28 am | by Sucampo Pharmaceuticals | News | Comments

The FDA has granted Fast Track Designation for cobiprostone, a locally acting chloride channel activator for the prevention of oral mucositis.

California Court Sides With Consumers in Generic Drug Fight

May 8, 2015 11:48 am | by Sudhin Thanawala, Associated Press | News | Comments

The California Supreme Court ruled that settlement agreements between pharmaceutical companies that keep cheaper, generic drugs off the market may be illegal if they include excessive cash payments.

FDA Questions Benefit of Cystic Fibrosis Drug From Vertex

May 8, 2015 11:39 am | by Matthew Perrone, AP Health Writer | News | Comments

The Food and Drug Administration said in an online review that the benefit was small and it is unclear if the addition of a second drug ingredient adds to the pill's effectiveness.

Synthetic Pot Leads to Nationwide Spike in Hospitalizations

May 8, 2015 11:29 am | by Dave Collins, Associated Press | News | Comments

A huge nationwide spike in hospitalizations last month was caused by a class of drugs often called synthetic marijuana, possibly illustrating the potency and dangers of the chemicals used to make them.

Mylan Launches Generic Seasonale Tablets

May 7, 2015 11:50 am | by Mylan N.V. | News | Comments

Mylan N.V. today announced the U.S. launch of Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg, which is the generic version of Teva's Seasonale Tablets.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading